Brain Tumor Treatment Satisfaction Survey

The recruitment status of this study is unknown because the information has not been verified recently.
Verified September 2009 by Methodist Healthcare.
Recruitment status was  Recruiting
Sponsor:
Information provided by:
Methodist Healthcare
ClinicalTrials.gov Identifier:
NCT00557375
First received: November 13, 2007
Last updated: September 17, 2009
Last verified: September 2009
  Purpose

Patients with recent diagnosis and treatment of a brain tumor will complete a short questionnaire concerning the patient's quality of life and emotional state since receiving treatment. Caregivers will complete a one-page questionnaire concerning the patient's quality of life and emotional state since receiving treatment.


Condition
Brain Tumors

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Cross-Sectional
Official Title: Treatment Satisfaction Survey for Brain Tumor Patients and Their Caregivers

Resource links provided by NLM:


Further study details as provided by Methodist Healthcare:

Primary Outcome Measures:
  • Overall satisfaction and emotional impact of treatments in patients who have undergone therapy(s)for brain tumors. [ Time Frame: (greater than or equal to 3 months) from first treatment for brain tumor ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Observational data about the treatment course and emotional well-being of the brain tumor patient as provided by the caregiver. [ Time Frame: (Greater than or equal to 3 months) from first treatment for brain tumor ] [ Designated as safety issue: No ]

Estimated Enrollment: 700
Study Start Date: June 2007
Estimated Study Completion Date: November 2009
Groups/Cohorts
1
Brain tumor patients
2
Caregivers of brain tumor patients

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population

Brain tumor patients and their caregivers

Criteria

Inclusion Criteria:

  • Patients who are between 3 months and one year out from treatment for their brain tumor
  • Karnofsky Performance Status (KPS) >= 60
  • Age 18 years or over, any gender, any race
  • "patient caregivers will be individuals who provide the most day-to-day care for their respective brain tumor patients

Exclusion Criteria:

  • No exclusions
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00557375

Contacts
Contact: Michael DeCuypere, BS mdecuypere@utmem.edu

Locations
United States, Tennessee
Methodist University Hospital Recruiting
Memphis, Tennessee, United States, 38104
Principal Investigator: Jeffrey M. Sorenson, MD         
Sponsors and Collaborators
Methodist Healthcare
Investigators
Principal Investigator: Jeffrey M. Sorenson, MD Methodist Healthcare
  More Information

No publications provided

Responsible Party: Jeffrey Sorenson, MD, Methodist Healthcare
ClinicalTrials.gov Identifier: NCT00557375     History of Changes
Other Study ID Numbers: MHIRB 2007-036
Study First Received: November 13, 2007
Last Updated: September 17, 2009
Health Authority: United States: Institutional Review Board

Keywords provided by Methodist Healthcare:
Brain Tumors
Survey

Additional relevant MeSH terms:
Brain Neoplasms
Neoplasms
Brain Diseases
Central Nervous System Diseases
Central Nervous System Neoplasms
Neoplasms by Site
Nervous System Diseases
Nervous System Neoplasms

ClinicalTrials.gov processed this record on October 30, 2014